APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propofol Injection for Operation General Anesthesia

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Propofol Injection for Operation General Anesthesia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchPropofol Injection for Operation General Anesthesia Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Injection for Operation General Anesthesia Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Propofol Injection for Operation General Anesthesia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Injection for Operation General Anesthesia Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Injection for Operation General Anesthesia Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Propofol Injection for Operation General Anesthesia market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Propofol Injection for Operation General Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol Injection for Operation General Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol Injection for Operation General Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Propofol Injection for Operation General Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Propofol Injection for Operation General Anesthesia include Yichang Humanwell, Xi'an Libang, Nhwa, Hengrui, China National Medicines Guorui Pharmaceutical Co.,Ltd., Fresenius-Kabi, Baxter Healthcare, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Propofol Injection for Operation General Anesthesia market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol Injection for Operation General Anesthesia and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol Injection for Operation General Anesthesia sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol Injection for Operation General Anesthesia market size, projected growth trends, production technologies, key applications, and end-use industries.

Propofol Injection for Operation General Anesthesia Segment by Company

Yichang Humanwell

Xi'an Libang

Nhwa

Hengrui

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Fresenius-Kabi

Baxter Healthcare

AbbVie

AstraZeneca

Piramal

Maruishi

Hikma Pharmaceuticals

B.Braun

Aspen Pharma

Propofol Injection for Operation General Anesthesia Segment by Type

10ml

20ml

50ml

Others

Propofol Injection for Operation General Anesthesia Segment by Application

Hopitals

Clinics

Others

Propofol Injection for Operation General Anesthesia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Injection for Operation General Anesthesia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Injection for Operation General Anesthesia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Injection for Operation General Anesthesia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Propofol Injection for Operation General Anesthesia market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Propofol Injection for Operation General Anesthesia manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Propofol Injection for Operation General Anesthesia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Propofol Injection for Operation General Anesthesia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Propofol Injection for Operation General Anesthesia Industry Trends Table 2. Propofol Injection for Operation General Anesthesia Industry Drivers Table 3. Propofol Injection for Operation General Anesthesia Industry Opportunities and Challenges Table 4. Propofol Injection for Operation General Anesthesia Industry Restraints Table 5. Global Propofol Injection for Operation General Anesthesia Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Propofol Injection for Operation General Anesthesia Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Manufacturers Table 9. Global Propofol Injection for Operation General Anesthesia Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Propofol Injection for Operation General Anesthesia Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Propofol Injection for Operation General Anesthesia Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Propofol Injection for Operation General Anesthesia Manufacturers, Product Type & Application Table 13. Global Propofol Injection for Operation General Anesthesia Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Propofol Injection for Operation General Anesthesia by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10ml Table 17. Major Manufacturers of 20ml Table 18. Major Manufacturers of 50ml Table 19. Major Manufacturers of Others Table 20. Global Propofol Injection for Operation General Anesthesia Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Propofol Injection for Operation General Anesthesia Sales by Type (2021-2026) & (k units) Table 22. Global Propofol Injection for Operation General Anesthesia Sales by Type (2027-2032) & (k units) Table 23. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2021-2026) Table 24. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2027-2032) Table 25. Global Propofol Injection for Operation General Anesthesia Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2026) & (k units) Table 27. Global Propofol Injection for Operation General Anesthesia Revenue by Type (2027-2032) & (k units) Table 28. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2021-2026) Table 29. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hopitals Table 31. Major Manufacturers of Clinics Table 32. Major Manufacturers of Others Table 33. Global Propofol Injection for Operation General Anesthesia Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Propofol Injection for Operation General Anesthesia Sales by Application (2021-2026) & (k units) Table 35. Global Propofol Injection for Operation General Anesthesia Sales by Application (2027-2032) & (k units) Table 36. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2021-2026) Table 37. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2027-2032) Table 38. Global Propofol Injection for Operation General Anesthesia Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2026) & (k units) Table 40. Global Propofol Injection for Operation General Anesthesia Revenue by Application (2027-2032) & (k units) Table 41. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2021-2026) Table 42. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2027-2032) Table 43. Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Propofol Injection for Operation General Anesthesia Sales by Region (2021-2026) & (k units) Table 45. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2021-2026) Table 46. Global Propofol Injection for Operation General Anesthesia Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Propofol Injection for Operation General Anesthesia Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Propofol Injection for Operation General Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 50. North America Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 51. Europe Propofol Injection for Operation General Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 53. Europe Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Propofol Injection for Operation General Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 60. Global Propofol Injection for Operation General Anesthesia Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Propofol Injection for Operation General Anesthesia Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Propofol Injection for Operation General Anesthesia Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2021-2026) Table 64. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2027-2032) Table 65. Yichang Humanwell Company Information Table 66. Yichang Humanwell Business Overview Table 67. Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Yichang Humanwell Propofol Injection for Operation General Anesthesia Product Portfolio Table 69. Yichang Humanwell Recent Development Table 70. Xi'an Libang Company Information Table 71. Xi'an Libang Business Overview Table 72. Xi'an Libang Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Xi'an Libang Propofol Injection for Operation General Anesthesia Product Portfolio Table 74. Xi'an Libang Recent Development Table 75. Nhwa Company Information Table 76. Nhwa Business Overview Table 77. Nhwa Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Nhwa Propofol Injection for Operation General Anesthesia Product Portfolio Table 79. Nhwa Recent Development Table 80. Hengrui Company Information Table 81. Hengrui Business Overview Table 82. Hengrui Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Hengrui Propofol Injection for Operation General Anesthesia Product Portfolio Table 84. Hengrui Recent Development Table 85. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information Table 86. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview Table 87. China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product Portfolio Table 89. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Development Table 90. Fresenius-Kabi Company Information Table 91. Fresenius-Kabi Business Overview Table 92. Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product Portfolio Table 94. Fresenius-Kabi Recent Development Table 95. Baxter Healthcare Company Information Table 96. Baxter Healthcare Business Overview Table 97. Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Baxter Healthcare Propofol Injection for Operation General Anesthesia Product Portfolio Table 99. Baxter Healthcare Recent Development Table 100. AbbVie Company Information Table 101. AbbVie Business Overview Table 102. AbbVie Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. AbbVie Propofol Injection for Operation General Anesthesia Product Portfolio Table 104. AbbVie Recent Development Table 105. AstraZeneca Company Information Table 106. AstraZeneca Business Overview Table 107. AstraZeneca Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. AstraZeneca Propofol Injection for Operation General Anesthesia Product Portfolio Table 109. AstraZeneca Recent Development Table 110. Piramal Company Information Table 111. Piramal Business Overview Table 112. Piramal Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Piramal Propofol Injection for Operation General Anesthesia Product Portfolio Table 114. Piramal Recent Development Table 115. Maruishi Company Information Table 116. Maruishi Business Overview Table 117. Maruishi Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Maruishi Propofol Injection for Operation General Anesthesia Product Portfolio Table 119. Maruishi Recent Development Table 120. Hikma Pharmaceuticals Company Information Table 121. Hikma Pharmaceuticals Business Overview Table 122. Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product Portfolio Table 124. Hikma Pharmaceuticals Recent Development Table 125. B.Braun Company Information Table 126. B.Braun Business Overview Table 127. B.Braun Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. B.Braun Propofol Injection for Operation General Anesthesia Product Portfolio Table 129. B.Braun Recent Development Table 130. Aspen Pharma Company Information Table 131. Aspen Pharma Business Overview Table 132. Aspen Pharma Propofol Injection for Operation General Anesthesia Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Aspen Pharma Propofol Injection for Operation General Anesthesia Product Portfolio Table 134. Aspen Pharma Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Propofol Injection for Operation General Anesthesia Distributors List Table 138. Propofol Injection for Operation General Anesthesia Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Propofol Injection for Operation General Anesthesia Product Image Figure 2. Global Propofol Injection for Operation General Anesthesia Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Injection for Operation General Anesthesia Market Size (2021-2032) & (US$ Million) Figure 4. Global Propofol Injection for Operation General Anesthesia Sales (2021-2032) & (k units) Figure 5. Global Propofol Injection for Operation General Anesthesia Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Propofol Injection for Operation General Anesthesia Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10ml Image Figure 9. 20ml Image Figure 10. 50ml Image Figure 11. Others Image Figure 12. Global Propofol Injection for Operation General Anesthesia Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Propofol Injection for Operation General Anesthesia Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2021-2032) Figure 15. Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Propofol Injection for Operation General Anesthesia Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2021-2032) Figure 18. Hopitals Image Figure 19. Clinics Image Figure 20. Others Image Figure 21. Global Propofol Injection for Operation General Anesthesia Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Propofol Injection for Operation General Anesthesia Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2021-2032) Figure 24. Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Propofol Injection for Operation General Anesthesia Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2021-2032) Figure 27. North America Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2032) Figure 29. U.S. Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2032) Figure 34. Germany Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2032) Figure 41. China Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2032) Figure 49. Brazil Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Propofol Injection for Operation General Anesthesia Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Propofol Injection for Operation General Anesthesia Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Figure 60. North America Propofol Injection for Operation General Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Figure 62. Europe Propofol Injection for Operation General Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Propofol Injection for Operation General Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Propofol Injection for Operation General Anesthesia Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Propofol Injection for Operation General Anesthesia Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml
  • 20ml
  • 50ml
  • Others
Applications
  • Hopitals
  • Clinics
  • Others
Companies covered
  • Yichang Humanwell
  • Xi'an Libang
  • Nhwa
  • Hengrui
  • China National Medicines Guorui Pharmaceutical Co.,Ltd.
  • Fresenius-Kabi
  • Baxter Healthcare
  • AbbVie
  • AstraZeneca
  • Piramal
  • Maruishi
  • Hikma Pharmaceuticals
  • B.Braun
  • Aspen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Propofol Injection for Operation General Anesthesia Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Propofol Injection for Operation General Anesthesia Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Propofol Injection for Operation General Anesthesia Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Propofol Injection for Operation General Anesthesia Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Propofol Injection for Operation General Anesthesia Market Dynamics
  1. 2.1 Propofol Injection for Operation General Anesthesia Industry Trends
  2. 2.2 Propofol Injection for Operation General Anesthesia Industry Drivers
  3. 2.3 Propofol Injection for Operation General Anesthesia Industry Opportunities and Challenges
  4. 2.4 Propofol Injection for Operation General Anesthesia Industry Restraints
3 Propofol Injection for Operation General Anesthesia Market by Manufacturers
  1. 3.1 Global Propofol Injection for Operation General Anesthesia Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Propofol Injection for Operation General Anesthesia Sales by Manufacturers (2021-2026)
  3. 3.3 Global Propofol Injection for Operation General Anesthesia Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Propofol Injection for Operation General Anesthesia Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Propofol Injection for Operation General Anesthesia Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Propofol Injection for Operation General Anesthesia Manufacturers, Product Type & Application
  7. 3.7 Global Propofol Injection for Operation General Anesthesia Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Propofol Injection for Operation General Anesthesia Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Propofol Injection for Operation General Anesthesia Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Propofol Injection for Operation General Anesthesia Tier 1, Tier 2, and Tier 3
4 Propofol Injection for Operation General Anesthesia Market by Type
  1. 4.1 Propofol Injection for Operation General Anesthesia Type Introduction
  2. 4.1.1 10ml
  3. 4.1.2 20ml
  4. 4.1.3 50ml
  5. 4.1.4 Others
  6. 4.2 Global Propofol Injection for Operation General Anesthesia Sales by Type
  7. 4.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032)
  9. 4.2.3 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2021-2032)
  10. 4.3 Global Propofol Injection for Operation General Anesthesia Revenue by Type
  11. 4.3.1 Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2032)
  13. 4.3.3 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2021-2032)
5 Propofol Injection for Operation General Anesthesia Market by Application
  1. 5.1 Propofol Injection for Operation General Anesthesia Application Introduction
  2. 5.1.1 Hopitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Propofol Injection for Operation General Anesthesia Sales by Application
  6. 5.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032)
  8. 5.2.3 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2021-2032)
  9. 5.3 Global Propofol Injection for Operation General Anesthesia Revenue by Application
  10. 5.3.1 Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2032)
  12. 5.3.3 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2021-2032)
6 Global Propofol Injection for Operation General Anesthesia Sales by Region
  1. 6.1 Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol Injection for Operation General Anesthesia Sales by Region (2021-2032)
  3. 6.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Region (2021-2026)
  4. 6.2.2 Global Propofol Injection for Operation General Anesthesia Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Propofol Injection for Operation General Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Propofol Injection for Operation General Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Propofol Injection for Operation General Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Propofol Injection for Operation General Anesthesia Revenue by Region
  1. 7.1 Global Propofol Injection for Operation General Anesthesia Revenue by Region
  2. 7.1.1 Global Propofol Injection for Operation General Anesthesia Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Propofol Injection for Operation General Anesthesia Revenue by Region (2021-2026)
  4. 7.1.3 Global Propofol Injection for Operation General Anesthesia Revenue by Region (2027-2032)
  5. 7.1.4 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Propofol Injection for Operation General Anesthesia Revenue (2021-2032)
  8. 7.2.2 North America Propofol Injection for Operation General Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Propofol Injection for Operation General Anesthesia Revenue (2021-2032)
  11. 7.3.2 Europe Propofol Injection for Operation General Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Propofol Injection for Operation General Anesthesia Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Propofol Injection for Operation General Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Propofol Injection for Operation General Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yichang Humanwell
  2. 8.1.1 Yichang Humanwell Company Information
  3. 8.1.2 Yichang Humanwell Business Overview
  4. 8.1.3 Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yichang Humanwell Propofol Injection for Operation General Anesthesia Product Portfolio
  6. 8.1.5 Yichang Humanwell Recent Developments
  7. 8.2 Xi'an Libang
  8. 8.2.1 Xi'an Libang Company Information
  9. 8.2.2 Xi'an Libang Business Overview
  10. 8.2.3 Xi'an Libang Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Libang Propofol Injection for Operation General Anesthesia Product Portfolio
  12. 8.2.5 Xi'an Libang Recent Developments
  13. 8.3 Nhwa
  14. 8.3.1 Nhwa Company Information
  15. 8.3.2 Nhwa Business Overview
  16. 8.3.3 Nhwa Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nhwa Propofol Injection for Operation General Anesthesia Product Portfolio
  18. 8.3.5 Nhwa Recent Developments
  19. 8.4 Hengrui
  20. 8.4.1 Hengrui Company Information
  21. 8.4.2 Hengrui Business Overview
  22. 8.4.3 Hengrui Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hengrui Propofol Injection for Operation General Anesthesia Product Portfolio
  24. 8.4.5 Hengrui Recent Developments
  25. 8.5 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  26. 8.5.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
  27. 8.5.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  28. 8.5.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product Portfolio
  30. 8.5.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
  31. 8.6 Fresenius-Kabi
  32. 8.6.1 Fresenius-Kabi Company Information
  33. 8.6.2 Fresenius-Kabi Business Overview
  34. 8.6.3 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product Portfolio
  36. 8.6.5 Fresenius-Kabi Recent Developments
  37. 8.7 Baxter Healthcare
  38. 8.7.1 Baxter Healthcare Company Information
  39. 8.7.2 Baxter Healthcare Business Overview
  40. 8.7.3 Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Baxter Healthcare Propofol Injection for Operation General Anesthesia Product Portfolio
  42. 8.7.5 Baxter Healthcare Recent Developments
  43. 8.8 AbbVie
  44. 8.8.1 AbbVie Company Information
  45. 8.8.2 AbbVie Business Overview
  46. 8.8.3 AbbVie Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie Propofol Injection for Operation General Anesthesia Product Portfolio
  48. 8.8.5 AbbVie Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Propofol Injection for Operation General Anesthesia Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 Piramal
  56. 8.10.1 Piramal Company Information
  57. 8.10.2 Piramal Business Overview
  58. 8.10.3 Piramal Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Piramal Propofol Injection for Operation General Anesthesia Product Portfolio
  60. 8.10.5 Piramal Recent Developments
  61. 8.11 Maruishi
  62. 8.11.1 Maruishi Company Information
  63. 8.11.2 Maruishi Business Overview
  64. 8.11.3 Maruishi Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Maruishi Propofol Injection for Operation General Anesthesia Product Portfolio
  66. 8.11.5 Maruishi Recent Developments
  67. 8.12 Hikma Pharmaceuticals
  68. 8.12.1 Hikma Pharmaceuticals Company Information
  69. 8.12.2 Hikma Pharmaceuticals Business Overview
  70. 8.12.3 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product Portfolio
  72. 8.12.5 Hikma Pharmaceuticals Recent Developments
  73. 8.13 B.Braun
  74. 8.13.1 B.Braun Company Information
  75. 8.13.2 B.Braun Business Overview
  76. 8.13.3 B.Braun Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 B.Braun Propofol Injection for Operation General Anesthesia Product Portfolio
  78. 8.13.5 B.Braun Recent Developments
  79. 8.14 Aspen Pharma
  80. 8.14.1 Aspen Pharma Company Information
  81. 8.14.2 Aspen Pharma Business Overview
  82. 8.14.3 Aspen Pharma Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aspen Pharma Propofol Injection for Operation General Anesthesia Product Portfolio
  84. 8.14.5 Aspen Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Propofol Injection for Operation General Anesthesia Value Chain Analysis
  2. 9.1.1 Propofol Injection for Operation General Anesthesia Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Propofol Injection for Operation General Anesthesia Production Mode & Process
  6. 9.2 Propofol Injection for Operation General Anesthesia Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Propofol Injection for Operation General Anesthesia Distributors
  9. 9.2.3 Propofol Injection for Operation General Anesthesia Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst